HomeRAPT • NASDAQ
add
Rapt Therapeutics Inc
Previous close
$7.93
Day range
$7.62 - $7.87
Year range
$6.86 - $27.35
Market cap
267.96M USD
Avg Volume
972.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 33.22M | 35.96% |
Net income | -30.88M | -34.53% |
Net profit margin | — | — |
Earnings per share | -0.81 | -26.56% |
EBITDA | -32.89M | -36.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 158.86M | -36.22% |
Total assets | 173.33M | -34.89% |
Total liabilities | 26.29M | 24.95% |
Total equity | 147.04M | — |
Shares outstanding | 34.80M | — |
Price to book | 1.86 | — |
Return on assets | -44.52% | — |
Return on capital | -49.70% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -30.88M | -34.53% |
Cash from operations | -27.75M | -21.47% |
Cash from investing | 20.64M | 150.01% |
Cash from financing | 458.00K | -99.39% |
Net change in cash | -6.66M | -159.23% |
Free cash flow | -16.71M | -24.00% |
About
Founded
2015
Headquarters
Website
Employees
131
